(alphaR,gammaS,2S)-alpha-Benzyl-2-(tert-butylcarbamoyl)-gamma-hydroxy-N-((1S,2R)-2-hydroxy-1-indanyl)-4-(3-pyridylmethyl)-1-piperazinevaleramide sulfate (1:1) (salt)

Synopsis, Chemistry

APIs // Active Pharmaceutical Ingredients

2 Suppliers, 2 USDMF

PRICE INFORMATION

API Reference Price

API Reference Price

INTERMEDIATES

2 Suppliers

2 Suppliers

DOSSIERs // Finished Dosage Forms

16 Dossiers, 4 FDA Orange Book, 5 Europe, 3 South Africa, 4 Listed Dossiers

DRUG PRODUCT COMPOSITION

CAPSULE;ORAL - EQ 200MG BASE, CAPSULE;ORAL - EQ 400MG BASE

RELATED EXCIPIENT COMPANIES

Suppliers, 7 Kerry, 6 Microlex e.U, 5 BASF, 4 ACG Worldwide, 3 Lonza Capsugel, 2 Roquette, 2 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 2 Gangwal Chemicals, 1 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 DFE Pharma, 1 Prachin Chemical, 1 Gangwal Healthcare, 1 Qualicaps, 1 Sigachi Industries, 1 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

12 Fillers, Diluents & Binders, 11 Lubricants & Glidants, 8 Empty Capsules, 5 Coating Systems & Additives, 4 Direct Compression, 3 Granulation, 3 Co-Processed Excipients, 3 Taste Masking, 2 Emulsifying Agents, 2 Thickeners and Stabilizers, 2 Controlled & Modified Release, 2 Film Formers & Plasticizers, 1 API Stability Enhancers, 1 Topical

GLOBAL SALES INFORMATION

8 US Medicaid Prescriptions, 3 Finished Drug Prices

PATENTS

4 Health Canada Patents

4 Health Canada Patents

ANALYTICAL SOLUTION(s)

1 EDQM Standards, 2 USP Standards, 2 Other Ref. Standards

Approved Marketing Authorisations (MA) containing (alphaR,gammaS,2S)-alpha-Benzyl-2-(tert-butylcarbamoyl)-gamma-hydroxy-N-((1S,2R)-2-hydroxy-1-indanyl)-4-(3-pyridylmethyl)-1-piperazinevaleramide sulfate (1:1) (salt) in Europe. Original Data : EMA Website

(alphaR,gammaS,2S)-alpha-Benzyl-2-(tert-butylcarbamoyl)-gamma-hydroxy-N-((1S,2R)-2-hydroxy-1-indanyl)-4-(3-pyridylmethyl)-1-piperazinevaleramide sulfate (1:1) (salt)

Synopsis

Chemistry

APIs // Active Pharmaceutical Ingredients

2 Suppliers

2 USDMF

PRICE INFORMATION

API Reference Price

INTERMEDIATES

2 Suppliers

DOSSIERs // Finished Dosage Forms

16 Dossiers

4 FDA Orange Book

5 Europe

3 South Africa

4 Listed Dossiers

DRUG PRODUCT COMPOSITION

CAPSULE;ORAL - EQ 200MG BASE

CAPSULE;ORAL - EQ 400MG BASE

RELATED EXCIPIENT COMPANIES

Suppliers

7 Kerry

6 Microlex e.U

5 BASF

4 ACG Worldwide

3 Lonza Capsugel

2 Roquette

2 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

2 Gangwal Chemicals

1 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

1 DFE Pharma

1 Prachin Chemical

1 Gangwal Healthcare

1 Qualicaps

1 Sigachi Industries

1 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

12 Fillers, Diluents & Binders

11 Lubricants & Glidants

8 Empty Capsules

5 Coating Systems & Additives

4 Direct Compression

3 Granulation

3 Co-Processed Excipients

3 Taste Masking

2 Emulsifying Agents

2 Thickeners and Stabilizers

2 Controlled & Modified Release

2 Film Formers & Plasticizers

1 API Stability Enhancers

1 Topical

GLOBAL SALES INFORMATION

8 US Medicaid Prescriptions

3 Finished Drug Prices

PATENTS

4 Health Canada Patents

ANALYTICAL SOLUTION(s)

1 EDQM Standards

2 USP Standards

2 Other Ref. Standards

HARD CAPSULES

400 MG

CRIXIVAN

Sweden

HARD CAPSULES

200 MG

CRIXIVAN

Sweden

Capsule

Crixivan, Kaps 200 mg, 360 Stk

Switzerland

Capsule

Crixivan, Kaps 400 mg, 180 Stk

Switzerland

Capsule, hard

400 mg

Crixivan

Box of plastic

Norway